Mitsubishi UFJ Asset Management Co. Ltd. Has $34.22 Million Position in The Cooper Companies, Inc. $COO

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 421,948 shares of the medical device company’s stock after purchasing an additional 23,896 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Cooper Companies were worth $34,224,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. JANA Partners Management LP acquired a new position in Cooper Companies during the third quarter valued at approximately $166,917,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies in the third quarter valued at approximately $11,341,000. Massachusetts Financial Services Co. MA lifted its stake in Cooper Companies by 96.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after buying an additional 1,525,693 shares in the last quarter. Alecta Tjanstepension Omsesidigt lifted its stake in Cooper Companies by 15.8% in the third quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after buying an additional 213,500 shares in the last quarter. Finally, DAVENPORT & Co LLC lifted its stake in Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after buying an additional 528,346 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $60.00 on Friday. The company’s fifty day simple moving average is $71.18 and its 200-day simple moving average is $76.08. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The firm has a market cap of $11.71 billion, a PE ratio of 29.70, a P/E/G ratio of 1.55 and a beta of 0.89. The Cooper Companies, Inc. has a 12 month low of $59.68 and a 12 month high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on COO. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Needham & Company LLC boosted their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a research report on Wednesday, March 4th. Finally, William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.